Your browser doesn't support javascript.
loading
Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells.
Newling, Melissa; Hoepel, Willianne; Vogelpoel, Lisa T C; Heineke, Marieke H; van Burgsteden, Johan A; Taanman-Kueter, Esther W M; Eggink, Dirk; Kuijpers, Taco W; Beaumont, Tim; van Egmond, Marjolein; Kapsenberg, Martien L; Baeten, Dominique L P; den Dunnen, Jeroen; Jong, Esther C de.
Afiliación
  • Newling M; Amsterdam Rheumatology and Immunology Center, location Academic Medical Center (AMC), Amsterdam, The Netherlands.
  • Hoepel W; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam, The Netherlands.
  • Vogelpoel LTC; Amsterdam Rheumatology and Immunology Center, location Academic Medical Center (AMC), Amsterdam, The Netherlands.
  • Heineke MH; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam, The Netherlands.
  • van Burgsteden JA; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam, The Netherlands.
  • Taanman-Kueter EWM; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Amsterdam, The Netherlands.
  • Eggink D; Amsterdam Rheumatology and Immunology Center, location Academic Medical Center (AMC), Amsterdam, The Netherlands.
  • Kuijpers TW; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam, The Netherlands.
  • Beaumont T; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam, The Netherlands.
  • van Egmond M; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology, Amsterdam, The Netherlands.
  • Kapsenberg ML; Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.
  • Baeten DLP; Department of Pediatric Hematology, Immunology and Infectious Disease, Emma Children's Hospital, AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • den Dunnen J; AIMM Therapeutics, AMC, Amsterdam, The Netherlands.
  • Jong EC; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Amsterdam, The Netherlands.
Eur J Immunol ; 48(11): 1796-1809, 2018 11.
Article en En | MEDLINE | ID: mdl-30184252
ABSTRACT
Type I and type III interferons (IFNs) are fundamental for antiviral immunity, but prolonged expression is also detrimental to the host. Therefore, upon viral infection high levels of type I and III IFNs are followed by a strong and rapid decline. However, the mechanisms responsible for this suppression are still largely unknown. Here, we show that IgG opsonization of model viruses influenza and respiratory syncytial virus (RSV) strongly and selectively suppressed type I and III IFN production by various human antigen-presenting cells. This suppression was induced by selective inhibition of TLR, RIG-I-like receptor, and STING-dependent type I and III IFN gene transcription. Surprisingly, type I and III IFN suppression was mediated by Syk and PI3K independent inhibitory signaling via FcγRIIa, thereby identifying a novel non-canonical FcγRIIa pathway in myeloid cells. Together, these results indicate that IgG opsonization of viruses functions as a novel negative feedback mechanism in humans, which may play a role in the selective suppression of type I and III IFN responses during the late-phase of viral infections. In addition, activation of this pathway may be used as a tool to limit type I IFN-associated pathology.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Interferones / Receptores de IgG / Células Mieloides Límite: Animals / Female / Humans Idioma: En Revista: Eur J Immunol Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Interferones / Receptores de IgG / Células Mieloides Límite: Animals / Female / Humans Idioma: En Revista: Eur J Immunol Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos